You are here

Management of Patients under Radiotherapy: skin toxicities

By Mario Lacouture, recorded at TAO (Transatlantic Oncology meeting), Nov 20-21, 2014, Paris

9 - Mario Lacouture ANG

Targeting of the cancer is accompanied by targeting of the skin, as almost every single cell in the epidermis and the dermis is affected by radiation. The resulting acute and chronic dermatologic toxicities can have a psychosocial impact if they affect areas of the body that are exposed to other people, constitute a financial burden as patients have to pay for the management of their toxicities, affect physical health because they can be very painful and lead to life-threatening or life-altering infections, and – most importantly – require treatment disruption. Mario Lacouture reviews early (e.g. erythema, moist desquamation, ulceration) and late adverse events (e.g. fibrosis, telangiectasia, xeroderma) as well as management strategies to prevent radiation dermatitis. With regard to skin care, an early and proactive approach towards adverse events is advisable.

Mario Lacouture, Memorial Sloan-Kettering Center, New York, USA

Search this site

Featured videos

Free access to ebooks on cachexia and CINV

 

Prevention of nausea and vomiting in
adult cancer patients receiving tumour-
directed therapy – 2017 update –

and
Cancer cachexia: mechanisms and progress in treatment

 

Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo

Share